Blood tests are inherently flawed, research has shown, because they don’t indicate how long the THC has been in the system, the driver’s tolerance, how high they actually are or whether they are impaired at that moment.
Cannabis smokers experience emphysema at higher rates than both non-smokers and tobacco smokers, according to new research from the Ottawa Hospital.
This “small but significant increase” in fatal motor vehicle accidents and fatalities could be curbed by effective regulations and educational campaigns, according to researchers.
AOAC International is now inviting submissions from cannabis laboratories with unique methods for mycotoxin screening and for the detection of Shiga toxin-producing Escherichia coli in cannabis plant materials and derivatives.
The International Association for the Study of Pain says it cannot currently endorse the general use of cannabis and cannabinoids for pain relief based on a lack of high-quality evidence.
California’s Honest Globe, Inc. and Michigan’s BioLyte Laboratories, LLC, have become the latest in a long line of companies to receive official warning letters from the FDA for the illegal marketing of unapproved CBD-containing drugs.